Vivos Inc. shares have been approved for trading on the OTCQB Marketplace as of Sept. 18.
Shares of the Richland, Wash.-based healthcare equipment company will trade under the symbol RDGL.
Vivos makes a brachytherapy injectable device, which is called IsoPet for use in animals and Radiogel for humans. The device directs highly localized radiation to treat cancerous tumors, allowing for the delivery of high doses to tumors that have resisted other treatments or cannot be removed via surgery.
